These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14976434)

  • 41. Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review.
    Marino A; Munafò A; Zagami A; Ceccarelli M; Campanella E; Cosentino F; Moscatt V; Cantarella G; Di Mauro R; Bernardini R; Nunnari G; Cacopardo B
    IDCases; 2022; 28():e01462. PubMed ID: 35265458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Native and Prosthetic Simultaneously Double Valve Infective Endocarditis with
    Haliga RE; Sorodoc V; Morarasu BC; Coman AE; Ceasovschih A; Sirbu O; Lionte C; Bologa C; Stoica A; Constantin M; Puha G; Petris OR; Badescu MC; Crisu D; Catana AN; Haliga IB; Sorodoc L
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ampicillin, gentamicin and teicoplanin as antimicrobial therapy for recurrent Streptococcus agalactiae and Enterococcus faecalis endocarditis in an intravenous drug abuser with HIV infection.
    Calza L; Manfredi R; Marinacci G; Fortunato L; Chiodo F
    Chemotherapy; 2003 Jul; 49(4):206-8. PubMed ID: 12886057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Resistance to antibiotics in clinical isolates of the genus Enterococcus].
    Martín MG; De Miguel I; Cañas A; Sánchez AM
    Rev Esp Quimioter; 2000 Dec; 13(4):412-6. PubMed ID: 11498710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.
    Wilson WR; Wilkowske CJ; Wright AJ; Sande MA; Geraci JE
    Ann Intern Med; 1984 Jun; 100(6):816-23. PubMed ID: 6426359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility profile of Enterococcus faecalis isolated at the Lagos University Teaching Hospital, Nigeria.
    Iregbu KC; Ogunsola FT; Odugbemi TO
    Niger Postgrad Med J; 2002 Sep; 9(3):125-8. PubMed ID: 12501265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility of enterococci in vitro.
    Tsaur SM; Chang SC; Luh KT; Hsieh WC
    J Formos Med Assoc; 1993 Jun; 92(6):547-52. PubMed ID: 8106043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of streptococcal infective endocarditis.
    Wilson WR; Geraci JE
    Am J Med; 1985 Jun; 78(6B):128-37. PubMed ID: 3925771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of oxazolidinone and phenicol resistant enterococcal isolates from duck feces and carcasses.
    Na SH; Moon DC; Choi MJ; Oh SJ; Jung DY; Kang HY; Hyun BH; Lim SK
    Int J Food Microbiol; 2019 Mar; 293():53-59. PubMed ID: 30640000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Enterococcus endocarditis model in experimental animals and its relevance to human infection.
    Gutschik E
    J Antimicrob Chemother; 1993 May; 31 Suppl D():87-95. PubMed ID: 8335527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibility pattern of Enterococcus species from urinary tract infections.
    Miskeen PA; Deodhar L
    J Assoc Physicians India; 2002 Mar; 50():378-81. PubMed ID: 11922226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A survey of antimicrobial susceptibility of clinical isolates of Enterococcus spp. from Irish hospitals.
    McNamara EB; King EM; Smyth EG
    J Antimicrob Chemother; 1995 Jan; 35(1):185-9. PubMed ID: 7768768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model.
    Houlihan HH; Stokes DP; Rybak MJ
    J Antimicrob Chemother; 2000 Jul; 46(1):79-86. PubMed ID: 10882693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN; Arnold RS; Gammie JS; Gilliam BL
    J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of susceptibility to antimicrobials of the enterococcal species isolated from pigeons (Columba livia).
    Butaye P; Baele M; Devriese LA; Haesebrouck F
    Microb Drug Resist; 2002; 8(3):215-8. PubMed ID: 12363011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
    Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A
    Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
    Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
    Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.